A vaccine called Gardasil has recently been released. It is highly effective in preventing persistent infection with two high-risk HPVs that cause most of cervical cancers.
The outlook for women with pre-cancerous changes of the cervix or very early cancer of the cervix is excellent; nearly all patients with these conditions can be cured.